SciLifeLab announces a call for new proposals to generate human recombinant antibodies. The call is open to academic users. Deadline for application is June 15, 2019.
The Human Antibody Therapeutics facility supports the development of therapeutic antibodies. SciLifeLiab will assist by isolating human antibodies from in-house constructed phage libraries to targets as suggested by the partner PI. It will be of critical importance that the partner PI has a substantial know-how of the biological system/target molecule, either from a clinical or basic scientific aspect. The objective is to deliver a reasonable number of candidate clones for further in vivo characterization in collaboration with the partner PI.